※ PTMD 2.0 database Online Browse Options
Browse result for Leukemia
※ introduction Leukemia (also spelled leukaemia and pronounced loo-KEE-mee-?) is a group of blood cancers that usually begin in the bone marrow and result in high numbers of abnormal blood cells. These blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising, bone pain, fatigue, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.
The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, petrochemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia¡ªacute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)¡ªas well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.
Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. Five-year survival rate is 65% in the United States. In children under 15 in first-world countries, the five-year survival rate is greater than 60% or even 90%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.
In 2015, leukemia was present in 2.3 million people worldwide and caused 353,500 deaths. In 2012, it had newly developed in 352,000 people. It is the most common type of cancer in children, with three-quarters of leukemia cases in children being the acute lymphoblastic type. However, over 90% of all leukemias are diagnosed in adults, with CLL and AML being most common in adults. It occurs more commonly in the developed world.
Reference
Wiki: Leukemia
Reference
Wiki: Leukemia
| PTMD ID | UniProt Accession | Entrez ID | Gene Name | Protein Name | Organism |
|---|---|---|---|---|---|
| PTMD00452 | O00459 | 5296 | PIK3R2 | Phosphatidylinositol 3-kinase regulatory subunit beta | Homo sapiens |
| PTMD00870 | O14980 | 7514 | XPO1 | Exportin-1 | Homo sapiens |
| PTMD00061 | O60674 | 3717 | JAK2 | Tyrosine-protein kinase JAK2 | Homo sapiens |
| PTMD01052 | P00519 | 25 | ABL1 | Tyrosine-protein kinase ABL1 | Homo sapiens |
| PTMD00644 | Q02548 | 5079 | PAX5 | Paired box protein Pax-5 | Homo sapiens |
| PTMD00660 | Q06124 | 5781 | PTPN11 | Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens |
| PTMD00251 | Q9BYW2 | 29072 | SETD2 | Histone-lysine N-methyltransferase SETD2 | Homo sapiens |
| PTMD00436 | Q9Y6K1 | 1788 | DNMT3A | DNA -methyltransferase 3A | Homo sapiens |
| PTMD00113 | Q9Y6N7 | 6091 | ROBO1 | Roundabout homolog 1 | Homo sapiens |
| PTMD00494 | O96028 | 7468 | NSD2 | Histone-lysine N-methyltransferase NSD2 | Homo sapiens |
| PTMD00225 | P68431 | 83508 | H3C1 | Histone H3.1 | Homo sapiens |
| PTMD00226 | P09429 | 3146 | HMGB1 | High mobility group protein B1 | Homo sapiens |
| PTMD00254 | P37173 | 7048 | TGFBR2 | TGF-beta receptor type-2 | Homo sapiens |
| PTMD00198 | P01111 | 4893 | NRAS | GTPase NRas | Homo sapiens |
| PTMD00498 | P01116 | 3845 | KRAS | GTPase KRas [Cleaved into: GTPase KRas, N-terminally processed] | Homo sapiens |
| PTMD00219 | P14618 | 5315 | PKM | Pyruvate kinase PKM | Homo sapiens |
| PTMD00896 | P18206 | 7414 | VCL | Vinculin | Homo sapiens |
| PTMD00576 | P30307 | 995 | CDC25C | M-phase inducer phosphatase 3 | Homo sapiens |
| PTMD00594 | P42702 | 3977 | LIFR | Leukemia inhibitory factor receptor | Homo sapiens |
| PTMD00031 | P46527 | 1027 | CDKN1B | Cyclin-dependent kinase inhibitor 1B | Homo sapiens |
| PTMD00224 | P62805 | 12150 | H4C1 | Histone H4 | Homo sapiens |
| PTMD01168 | Q99062 | 1441 | CSF3R | Granulocyte colony-stimulating factor receptor | Homo sapiens |
| PTMD01307 | P46109 | 1399 | CRKL | Crk-like protein | Homo sapiens |
| PTMD01394 | A0A7S8LV65 | RUNX1/RUNX1T1 | RUNX1-RUNX1T1 fusion protein | Homo sapiens | |
| PTMD01560 | P24752 | 38 | ACAT1 | Acetyl-CoA acetyltransferase, mitochondrial | Homo sapiens |
| PTMD01582 | P29590 | 5371 | PML | Protein PML | Homo sapiens |
| PTMD01649 | P51575 | 5023 | P2RX1 | P2X purinoceptor 1 | Homo sapiens |
| PTMD03586 | P00488 | 2162 | F13A1 | Coagulation factor XIII A chain | Homo sapiens |
| PTMD05359 | P49917 | 3981 | LIG4 | DNA ligase 4 | Homo sapiens |
| PTMD10691 | Q8WZ60 | 89857 | KLHL6 | Kelch-like protein 6 | Homo sapiens |
| PTMD14365 | Q9ULB4 | 1007 | CDH9 | Cadherin-9 | Homo sapiens |
| PTMD00636 | P68433 | 31915 | H3c1 | Histone H3.1 | Mus musculus |
| PTMD01053 | P01103 | 39624 | MYB | Transcriptional activator Myb | Gallus gallus |
| PTMD01096 | P42230 | 20850 | Stat5a | Signal transducer and activator of transcription 5A | Mus musculus |
| PTMD01956 | Q9Z1S0 | 12236 | Bub1b | Mitotic checkpoint serine/threonine-protein kinase BUB1 beta | Mus musculus |
